The following post was first published in OB/GYN News. Please see our OB/GYN News archives here. Publish date: April 23, 2018 The last two decades have seen an ever-growing number of reports on risks of fetal exposure to [...]
When we meet with women reporting premenstrual symptoms, we often recommend that they avoid the use of alcohol. Analyzing 19 previously published studies of alcohol and PMS, researcher found that risk for PMS risk [...]
An updated meta-analysis (Zhou et al, 2018) did not reveal an association between antidepressant exposure during pregnancy and increased risk of autism spectrum disorders. It is noteworthy that this publication -- one that would provide [...]
The American College of Obstetricians and Gynecologists (ACOG) has made a significant change to its recommendations for optimal postpartum care. Previously, ACOG has recommended that women receive a single, comprehensive postpartum visit within the first [...]
Each year in the United States, the menopause transition is experienced by 1.5 million women. With this change in the hormonal milieu comes troublesome symptoms, including vasomotor symptoms, decreased libido, insomnia, changes in mood, fatigue, [...]
We have, over the last twenty years, seen many studies assessing the risks associated with prenatal exposure to antidepressants. For the serotonin reuptake inhibitors (SRIs), we have a fairly large body of data regarding the [...]
The article that has received the most media attention over the last few weeks is at the top of the list. We will be covering this in greater detail next week. In brief, this is [...]
The title of the following article did not grab my attention; however, I discovered that this study, entitled Accuracy of the Whooley questions and the Edinburgh Postnatal Depression Scale in identifying depression and other [...]
Serotonin reuptake inhibitor (SRI) antidepressants may affect platelet aggregation and thus may increase the risk of bleeding. Over the last few years, we have seen several studies which have sought to determine if exposure [...]
Following the release of the MGH Perinatal Depression Scale (MGHPDS) on the App Store this past August, we are pleased to announce that the MGHPDS is now available for Android devices on the Google [...]
